Keywords
Last Name
Institution

Samin K. Sharma

TitleDEAN OF INTERNATIONAL CLINICAL AFFILIATIONS
InstitutionMount Sinai
AddressGuggenheim Pavilion
1190 Fifth Avenue - 1 South
New York NY 10029
Phone212-427-1540
Fax212-534-2845
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentCardiology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR, Stamato NJ, Venditti FJ, Gold JP, Sharma S, King SB. Assessment of the new appropriate use criteria for diagnostic catheterization in the detection of coronary artery disease following noninvasive stress testing. Int J Cardiol. 2014 Jan 1; 170(3):371-5.
      View in: PubMed
    2. Tomey MI, Gidwani UK, Sharma SK. Cardiac critical care after transcatheter aortic valve replacement. Cardiol Clin. 2013 Nov; 31(4):607-18.
      View in: PubMed
    3. Gidwani UK, Sharma SK, Kini AS. Cardiovascular intensive care. Cardiol Clin. 2013 Nov; 31(4):xiii-xiv.
      View in: PubMed
    4. Ali ZA, Roleder T, Narula J, Mohanty BD, Baber U, Kovacic JC, Mintz GS, Otsuka F, Pan S, Virmani R, Sharma SK, Moreno P, Kini AS. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv. 2013 Oct 1; 6(5):507-17.
      View in: PubMed
    5. Hannan EL, Zhong Y, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Holmes DR, Sharma S, Gesten F, King SB. Underutilization of percutaneous coronary intervention for ST-elevation myocardial infarction in medicaid patients relative to private insurance patients. J Interv Cardiol. 2013 Oct; 26(5):470-81.
      View in: PubMed
    6. Kovacic JC, Sharma AB, Roy S, Li JR, Narayan R, Kim DB, Sharma SK, Kini AS. GuideLiner mother-and-child guide catheter extension: a simple adjunctive tool in PCI for balloon uncrossable chronic total occlusions. J Interv Cardiol. 2013 Aug; 26(4):343-50.
      View in: PubMed
    7. Baber U, Kini AS, Moreno PR, Sharma SK. Aortic stenosis: role of balloon aortic valvuloplasty. Cardiol Clin. 2013 Aug; 31(3):327-36.
      View in: PubMed
    8. Madder RD, Goldstein JA, Madden SP, Puri R, Wolski K, Hendricks M, Sum ST, Kini A, Sharma S, Rizik D, Brilakis ES, Shunk KA, Petersen J, Weisz G, Virmani R, Nicholls SJ, Maehara A, Mintz GS, Stone GW, Muller JE. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2013 Aug; 6(8):838-46.
      View in: PubMed
    9. Kovacic JC, Limaye AM, Sartori S, Lee P, Patel R, Chandela S, Trost B, Roy S, Harari R, Narechania B, Karajgikar R, Kim MC, Krishnan P, Moreno P, Baber U, Mehran R, Dangas G, Kini AS, Sharma SK. Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization. Catheter Cardiovasc Interv. 2013 Nov 15; 82(6):855-68.
      View in: PubMed
    10. Wu C, Dyer AM, Walford G, Holmes DR, King SB, Stamato NJ, Sharma S, Jacobs AK, Venditti FJ, Hannan EL. Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents. Am J Cardiol. 2013 Sep 15; 112(6):775-81.
      View in: PubMed
    11. Hannan EL, Farrell LS, Walford G, Jacobs AK, Berger PB, Holmes DR, Stamato NJ, Sharma S, King SB. The New York State risk score for predicting in-hospital/30-day mortality following percutaneous coronary intervention. JACC Cardiovasc Interv. 2013 Jun; 6(6):614-22.
      View in: PubMed
    12. Baber U, Bander J, Karajgikar R, Yadav K, Hadi A, Theodoropolous K, Gukathasan N, Roy S, Sayeneni S, Scott SA, Kovacic JC, Yu J, Sartori S, Mehran R, Uribarri J, Badimon JJ, Muntner P, Moreno P, Kini AS, Sharma SK. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost. 2013 Jul; 110(1):118-23.
      View in: PubMed
    13. Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013 Jul 2; 62(1):21-9.
      View in: PubMed
    14. Kovacic JC, Nguyen HT, Karajgikar R, Sharma SK, Kini AS. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013 Jul 1; 82(1):E28-37.
      View in: PubMed
    15. O'Neill B, Singh V, Kini A, Mehran R, Jacobs E, Knopf D, Alfonso CE, Martinez CA, Martinezclark P, O'Neill W, Heldman AW, Yu J, Baber U, Kovacic JC, Dangas G, Sharma S, Sartori S, Cohen MG. The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub-analysis of the BRAVO study. Catheter Cardiovasc Interv. 2014 Jan 1; 83(1):148-53.
      View in: PubMed
    16. Hannan EL, Zhong Y, Wu C, Walford G, Holmes DR, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, Fergus I, King SB. Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State. Catheter Cardiovasc Interv. 2013 Jun 1; 81(7):1097-105.
      View in: PubMed
    17. Holmes DR, Lerman A, Moreno PR, King SB, Sharma SK. Diagnosis and management of STEMI arising from plaque erosion. JACC Cardiovasc Imaging. 2013 Mar; 6(3):290-6.
      View in: PubMed
    18. Kim M, Muntner P, Sharma S, Choi JW, Stoler RC, Woodward M, Mann DM, Farkouh ME. Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2013 Mar 1; 6(2):186-92.
      View in: PubMed
    19. Hannan EL, Samadashvili Z, Walford G, Jacobs AK, Stamato NJ, Venditti FJ, Holmes DR, Sharma S, King SB. Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2013 Feb; 6(1):12-20.
      View in: PubMed
    20. Roleder T, Sharma R, Kini AS, Moreno P, Sharma SK. Imaging of postpartum coronary artery's spontaneous dissection treated with stents implantation. Eur Heart J Cardiovasc Imaging. 2013 May; 14(5):503.
      View in: PubMed
    21. Narayan RL, Vaishnava P, Goldman ME, Stelzer P, Clark L, Kini AS, Sharma SK, Love B. Percutaneous closure of left ventricular pseudoaneurysm. Ann Thorac Surg. 2012 Nov; 94(5):e123-5.
      View in: PubMed
    22. Hermiller JB, Rutledge DR, Gruberg L, Katopodis JN, Lombardi W, Mao VW, Zhao W, Sharma SK, Tamboli HP, Wang J, Jonnavithula L, Sudhir K, Krucoff MW. Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. J Interv Cardiol. 2012 Dec; 25(6):565-75.
      View in: PubMed
    23. Sarkar K, Sardella G, Romeo F, De Benedictis M, Tarsia G, Iadanza A, Sharma SK, Barbanti M, Tamburino C, Ussia GP. Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves. Catheter Cardiovasc Interv. 2013 Apr; 81(5):864-70.
      View in: PubMed
    24. Purushothaman M, Krishnan P, Purushothaman KR, Baber U, Tarricone A, Perez JS, Wiley J, Kini A, Sharma SK, Fuster V, Moreno PR. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2769-75.
      View in: PubMed
    25. Purushothaman KR, Purushothaman M, Levy AP, Lento PA, Evrard S, Kovacic JC, Briley-Saebo KC, Tsimikas S, Witztum JL, Krishnan P, Kini A, Fayad ZA, Fuster V, Sharma SK, Moreno PR. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. J Am Coll Cardiol. 2012 Jul 10; 60(2):112-9.
      View in: PubMed
    26. Purushothaman KR, Krishnan P, Purushothaman M, Wiley J, Alviar CL, Ruiz FJ, Zubatov Y, Kini AS, Sharma SK, Fuster V, Moreno PR. Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization. Cardiovasc Pathol. 2013 Jan-Feb; 22(1):42-8.
      View in: PubMed
    27. Kovacic JC, Lee P, Karajgikar R, Baber U, Narechania B, Suleman J, Moreno PR, Sharma SK, Kini AS. Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice. J Interv Cardiol. 2012 Oct; 25(5):482-92.
      View in: PubMed
    28. Bander J, Elmariah S, Aledort LM, Dlott J, Stelzer P, Halperin JL, Kini AS, Sharma SK. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty. Thromb Haemost. 2012 Jul; 108(1):86-93.
      View in: PubMed
    29. Hannan EL, Cozzens K, Samadashvili Z, Walford G, Jacobs AK, Holmes DR, Stamato NJ, Sharma S, Venditti FJ, Fergus I, King SB. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J Am Coll Cardiol. 2012 May 22; 59(21):1870-6.
      View in: PubMed
    30. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR, Stamato NJ, Gold JP, Sharma S, Venditti FJ, Powell T, King SB. Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation. 2012 Apr 17; 125(15):1870-9.
      View in: PubMed
    31. Ali ZA, Kini A, Sharma SK. On OCT and finding the uncovered tracks... JACC Cardiovasc Imaging. 2012 Jan; 5(1):83-6.
      View in: PubMed
    32. Kovacic JC, Sharma SK, Kini AS. Bilateral coronary ostial stenoses post-Bentall procedure causing hemodynamic collapse and requiring mechanical assist device placement: successful intervention using the Szabo technique. Catheter Cardiovasc Interv. 2012 Apr 1; 79(5):801-4.
      View in: PubMed
    33. Hannan EL, Zhong Y, Krumholz H, Walford G, Holmes DR, Stamato NJ, Jacobs AK, Venditti FJ, Sharma S, King SB. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state. JACC Cardiovasc Interv. 2011 Dec; 4(12):1335-42.
      View in: PubMed
    34. Krucoff MW, Rutledge DR, Gruberg L, Jonnavithula L, Katopodis JN, Lombardi W, Mao VW, Sharma SK, Simonton CA, Tamboli HP, Wang J, Wilburn O, Zhao W, Sudhir K, Hermiller JB. A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). JACC Cardiovasc Interv. 2011 Dec; 4(12):1298-309.
      View in: PubMed
    35. Kovacic JC, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, Mehran R, Fuster V, Dangas G, Sharma SK, Kini AS. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis. 2012 Mar; 221(1):176-82.
      View in: PubMed
    36. Kovacic JC, Mehran R, Karajgikar R, Baber U, Suleman J, Kim MC, Krishnan P, Dangas G, Sharma SK, Kini A. Female gender and mortality after percutaneous coronary intervention: results from a large registry. Catheter Cardiovasc Interv. 2012 Oct 1; 80(4):514-21.
      View in: PubMed
    37. Vaishnava P, Pyo R, Filsoufi F, Sharma S. Compression of an anomalous left circumflex artery after aortic and mitral valve replacement. Ann Thorac Surg. 2011 Nov; 92(5):1887-9.
      View in: PubMed
    38. Wu C, Dyer AM, King SB, Walford G, Holmes DR, Stamato NJ, Venditti FJ, Sharma SK, Fergus I, Jacobs AK, Hannan EL. Impact of incomplete revascularization on long-term mortality after coronary stenting. Circ Cardiovasc Interv. 2011 Oct 1; 4(5):413-21.
      View in: PubMed
    39. Goldstein JA, Maini B, Dixon SR, Brilakis ES, Grines CL, Rizik DG, Powers ER, Steinberg DH, Shunk KA, Weisz G, Moreno PR, Kini A, Sharma SK, Hendricks MJ, Sum ST, Madden SP, Muller JE, Stone GW, Kern MJ. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011 Oct 1; 4(5):429-37.
      View in: PubMed
    40. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011 Oct 4; 58(15):1569-77.
      View in: PubMed
    41. Baber U, Kovacic J, Kini AS, Sharma SK, Dangas G, Mehran R. How serious a problem is bleeding in patients with acute coronary syndromes? Curr Cardiol Rep. 2011 Aug; 13(4):312-9.
      View in: PubMed
    42. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, Fergus I, King SB. Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction. Am J Cardiol. 2011 May 1; 107(9):1311-8.
      View in: PubMed
    43. Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis. J Thorac Cardiovasc Surg. 2011 Oct; 142(4):895-901.
      View in: PubMed
    44. Purushothaman KR, Purushothaman M, Muntner P, Lento PA, O'Connor WN, Sharma SK, Fuster V, Moreno PR. Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis. Vasc Med. 2011 Apr; 16(2):103-8.
      View in: PubMed
    45. Bashey S, Muntner P, Kini AS, Esquitin R, Razzouk L, Mathewkutty S, Wildman RP, Carson AP, Kim MC, Moreno PR, Sharma SK, Farkouh ME. Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention. Am J Cardiol. 2011 May 15; 107(10):1415-20.
      View in: PubMed
    46. Elmariah S, Lubitz SA, Shah AM, Miller MA, Kaplish D, Kothari S, Moreno PR, Kini AS, Sharma SK. A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score. Catheter Cardiovasc Interv. 2011 Jul 1; 78(1):112-8.
      View in: PubMed
    47. El-Atat F, Sarkar K, Kodali V, Karajgikar R, Jakkulla M, Mares A, Sharma S, Kini A. A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention. J Invasive Cardiol. 2011 Jan; 23(1):9-13.
      View in: PubMed
    48. Kovacic JC, Khanna D, Kaplish D, Karajgikar R, Sharma SK, Kini A. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction. J Invasive Cardiol. 2010 Dec; 22(12):586-91.
      View in: PubMed
    49. Dangas GD, Sharma SK, Mehran R. Acute myocardial infarction and multivessel disease: some vessels are more equal than others. Heart. 2010 Dec; 96(24):1955-6.
      View in: PubMed
    50. Sharma SK. Role of AngioJet rheolytic thrombectomy catheter: Mount Sinai Hospital experience. J Invasive Cardiol. 2010 Oct; 22(10 Suppl B):15B-20B.
      View in: PubMed
    51. Brodie BR, Sianos G, Grines CL, Antoniucci D, Mehta S, Sharma SK. Panel summary and recommendations on the role of thrombectomy with primary PCI for STEMI. J Invasive Cardiol. 2010 Oct; 22(10 Suppl B):34B-35B.
      View in: PubMed
    52. Baber U, Kini AS, Sharma SK. Stenting of complex lesions: an overview. Nat Rev Cardiol. 2010 Sep; 7(9):485-96.
      View in: PubMed
    53. Patel M, Kim M, Karajgikar R, Kodali V, Kaplish D, Lee P, Moreno P, Krishnan P, Sharma SK, Kini AS. Outcomes of patients discharged the same day following percutaneous coronary intervention. JACC Cardiovasc Interv. 2010 Aug; 3(8):851-8.
      View in: PubMed
    54. Hannan EL, Zhong Y, Jacobs AK, Holmes DR, Walford G, Venditti FJ, Stamato NJ, Sharma S, King SB. Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for st-segment elevation myocardial infarction. Am J Cardiol. 2010 Jul 15; 106(2):143-7.
      View in: PubMed
    55. Sharma SK. Oral antiplatelet therapy in PCI patients. Catheter Cardiovasc Interv. 2010 Mar 1; 75 Suppl 1:S7-14.
      View in: PubMed
    56. Lasala JM, Mehran R, Moses JW, Popma JJ, Reiner JS, Sharma SK, Vetrovec GW. Evidence based management of patients undergoing PCI. Conclusion. Catheter Cardiovasc Interv. 2010 Mar 1; 75 Suppl 1:S43-5.
      View in: PubMed
    57. Baber U, Akhter M, Kothari S, Sharma SK, Kini A. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol. 2010 Feb; 22(2):80-3.
      View in: PubMed
    58. Sharma SK, Kini AS. Preface. Cardiol Clin. 2010 Feb; 28(1):xi-xii.
      View in: PubMed
    59. Sharma SK, Sweeny J, Kini AS. Coronary bifurcation lesions: a current update. Cardiol Clin. 2010 Feb; 28(1):55-70.
      View in: PubMed
    60. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010 Jan; 3(1):22-31.
      View in: PubMed
    61. Kini AS, Rafael OC, Sarkar K, Rajdev S, Jakkula M, Mares AM, Kaplish D, Krishnan P, Kim MC, Sharma SK. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Catheter Cardiovasc Interv. 2009 Nov 1; 74(5):700-7.
      View in: PubMed
    62. Razzouk L, Muntner P, Bansilal S, Kini AS, Aneja A, Mozes J, Ivan O, Jakkula M, Sharma S, Farkouh ME. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. Am Heart J. 2009 Aug; 158(2):277-83.
      View in: PubMed
    63. Kini AS, Sarkar K, Rafael OC, Jakkula M, Kaplish D, Lee P, Suleman J, Krishnan P, Kim MC, Sharma SK. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function. Catheter Cardiovasc Interv. 2009 Jul 1; 74(1):49-55.
      View in: PubMed
    64. Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009 Jul; 4(7):1162-9.
      View in: PubMed
    65. Baber U, Kini AS, Sharma SK, Kim MC, Farkouh ME, Muntner P. Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. Am J Cardiol. 2009 Jun 1; 103(11):1513-7.
      View in: PubMed
    66. Sarkar K, Sharma SK, Kini AS. Catheter selection for coronary angiography and intervention in anomalous right coronary arteries. J Interv Cardiol. 2009 Jun; 22(3):234-9.
      View in: PubMed
    67. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs A, Sharma S, Katz S, King SB. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. JACC Cardiovasc Interv. 2009 Apr; 2(4):350-6.
      View in: PubMed
    68. Staniloae CS, Doucet S, Sharma SK, Katholi RE, Mody KR, Coppola JT, Solomon R. N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study. J Interv Cardiol. 2009 Jun; 22(3):261-5.
      View in: PubMed
    69. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv. 2009 Jan; 2(1):17-25.
      View in: PubMed
    70. Kini AS, Muntner P, Moreno PR, Mann D, Krishnan P, Kim MC, Rafael OC, Farkouh ME, Sharma SK. Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl. Am J Cardiol. 2009 Feb 1; 103(3):350-4.
      View in: PubMed
    71. Sharma SK. Do things that make sense to further improve STEMI treatment. J Invasive Cardiol. 2008 Nov; 20(11):A6, A8.
      View in: PubMed
    72. Kini AS, Chen VH, Krishnan P, Lee P, Kim MC, Mares A, Suleman J, Moreno PR, Sharma SK. Bolus-only versus bolus + infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. Am Heart J. 2008 Sep; 156(3):513-9.
      View in: PubMed
    73. Sharma SK. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent? J Invasive Cardiol. 2008 May; 20(5):245-8.
      View in: PubMed
    74. Hannan EL, Racz M, Holmes DR, Walford G, Sharma S, Katz S, Jones RH, King SB. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents. Circulation. 2008 Apr 22; 117(16):2071-8.
      View in: PubMed
    75. Hannan EL, Racz M, Walford G, Holmes DR, Jones RH, Sharma S, Katz S, King SB. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008 Apr; 1(2):129-35.
      View in: PubMed
    76. Stevens GR, Kini AS, Sharma SK. Intervention of stenosed right coronary artery and anomalous left main coronary artery: single main coronary trunk. J Invasive Cardiol. 2008 Mar; 20(3):E71-2.
      View in: PubMed
    77. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008 Feb; 20(2):67-72.
      View in: PubMed
    78. Kunamneni PB, Rajdev S, Krishnan P, Moreno PR, Kim MC, Sharma SK, Kini AS. Outcome of intracoronary stenting after failed maximal medical therapy in patients with symptomatic myocardial bridge. Catheter Cardiovasc Interv. 2008 Feb 1; 71(2):185-90.
      View in: PubMed
    79. Kini AS, Kim MC, Moreno PR, Krishnan P, Ivan OC, Sharma SK. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial). Am J Cardiol. 2008 Mar 15; 101(6):796-800.
      View in: PubMed
    80. Rajdev S, Irani A, Sharma S, Kini A. Clinical utility of TandemHeart for high-risk tandem procedures: percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol. 2007 Nov; 19(11):E346-9.
      View in: PubMed
    81. Filsoufi F, Rahmanian PB, Castillo JG, Mechanick JI, Sharma SK, Adams DH. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2007 Dec; 6(6):753-8.
      View in: PubMed
    82. Sinha AK, Kini AS, Sharma SK. Percutaneous valve replacement: a paradigm shift. Curr Opin Cardiol. 2007 Sep; 22(5):471-7.
      View in: PubMed
    83. Hannan EL, Racz M, Holmes DR, Sharma S, Katz S, Walford G, King SB, Clark LT, Jones RH. A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents. Am Heart J. 2007 Sep; 154(3):545-53.
      View in: PubMed
    84. Hannan EL, Racz M, Walford G, Clark LT, Holmes DR, King SB, Sharma S. Differences in utilization of drug-eluting stents by race and payer. Am J Cardiol. 2007 Oct 15; 100(8):1192-8.
      View in: PubMed
    85. Anand SX, Kim MC, Kamran M, Sharma SK, Kini AS, Fareed J, Hoppensteadt DA, Carbon F, Cavusoglu E, Varon D, Viles-Gonzalez JF, Badimon JJ, Marmur JD. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol. 2007 Aug 1; 100(3):417-24.
      View in: PubMed
    86. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007 Jun 26; 115(25):3189-96.
      View in: PubMed
    87. Bansilal S, Farkouh M, Sharma S, Fuster V. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting. Indian Heart J. 2007 Mar-Apr; 59(2 Suppl B):B72-82.
      View in: PubMed
    88. Goldbarg S, Kumar N, Sharma S. Images in cardiovascular medicine. Cardiac leiomyosarcoma. Circulation. 2007 Jan 30; 115(4):e47-8.
      View in: PubMed
    89. Spektor G, Gehi AK, Love B, Sharma SK, Fuster V. A case of symptomatic coronary artery fistula. Nat Clin Pract Cardiovasc Med. 2006 Dec; 3(12):689-92.
      View in: PubMed
    90. Sharma SK, Tamburrino F, Mares AM, Kini AS. Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus. J Invasive Cardiol. 2006 Jul; 18 Suppl C:C8-11.
      View in: PubMed
    91. Sarkar K, Sharma SK, Sachdeva R, Romeo F, Garza L, Mehta JL. Coronary artery restenosis: vascular biology and emerging therapeutic strategies. Expert Rev Cardiovasc Ther. 2006 Jul; 4(4):543-56.
      View in: PubMed
    92. Hannan EL, Racz M, Holmes DR, King SB, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006 May 23; 113(20):2406-12.
      View in: PubMed
    93. Sharma SK, Chen V. Coronary interventional devices: balloon, atherectomy, thrombectomy and distal protection devices. Cardiol Clin. 2006 May; 24(2):201-15, vi.
      View in: PubMed
    94. Sharma SK, Kini AS. Coronary bifurcation lesions. Cardiol Clin. 2006 May; 24(2):233-46, vi.
      View in: PubMed
    95. Sharma SK. Update in management of coronary bifurcation lesions in the drug-eluting stent era. Indian Heart J. 2006 Mar-Apr; 58(2):108-19.
      View in: PubMed
    96. Oliver B, Sharma SK, Ayello EA. Open new care pathways with drug-eluting stents. Nurs Manage. 2006 Feb; 37(2):33-9; quiz 39-40.
      View in: PubMed
    97. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes DR, King SB, Clark LT, Katz S, Sharma S, Jones RH. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006 Feb 7; 47(3):654-60.
      View in: PubMed
    98. Kini AS, Moreno PR, Steinheimer AM, Prattipati M, Suleman J, Kim MC, Sharma SK. Effectiveness of the stent pull-back technique for nonaorto ostial coronary narrowings. Am J Cardiol. 2005 Oct 15; 96(8):1123-8.
      View in: PubMed
    99. Hannan EL, Wu C, Walford G, King SB, Holmes DR, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation. 2005 Aug 23; 112(8):1171-9.
      View in: PubMed
    100. Sharma SK, Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv. 2005 Jul; 65(3):386-93.
      View in: PubMed
    101. Bagga R, Kini A, Lee P, Agarwal A, Duffy M, Kim M, Sharma S. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis. J Invasive Cardiol. 2005 Jun; 17(6):302-6.
      View in: PubMed
    102. Sharma SK. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv. 2005 May; 65(1):10-6.
      View in: PubMed
    103. Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O'Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J. 2005 Apr; 149(4):689-94.
      View in: PubMed
    104. Winslow RD, Sharma SK, Kim MC. Restenosis and drug-eluting stents. Mt Sinai J Med. 2005 Mar; 72(2):81-9.
      View in: PubMed
    105. Oliver B, Sharma SK, Ayello EA. How drug-eluting stents keep coronary blood flowing. Nursing. 2005 Feb; 35(2):36-41; quiz 41-2.
      View in: PubMed
    106. Agarwal A, Kini AS, Attanti S, Lee PC, Ashtiani R, Steinheimer AM, Moreno PR, Sharma SK. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005 Jan 1; 95(1):43-7.
      View in: PubMed
    107. Sharma SK. Is mortality raised in patients receiving percutaneous coronary intervention if they suffer from anemia? Nat Clin Pract Cardiovasc Med. 2004 Dec; 1(2):74-5.
      View in: PubMed
    108. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, Steinheimer AM, Kini AS. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol. 2004 Oct 1; 94(7):913-7.
      View in: PubMed
    109. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, Badimon JJ, O'Connor WN. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004 Oct 5; 110(14):2032-8.
      View in: PubMed
    110. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2004 Aug 4; 44(3):541-6.
      View in: PubMed
    111. Cavusoglu E, Kini AS, Marmur JD, Sharma SK. Current status of rotational atherectomy. Catheter Cardiovasc Interv. 2004 Aug; 62(4):485-98.
      View in: PubMed
    112. Stankovic G, Colombo A, Bersin R, Popma J, Sharma S, Cannon LA, Gordon P, Nukta D, Braden G, Collins M. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. Am J Cardiol. 2004 Apr 15; 93(8):953-8.
      View in: PubMed
    113. Sharma SK. A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol. 2004 Feb 15; 93(4):524-5.
      View in: PubMed
    114. Sharma SK, Kini A, Mehran R, Lansky A, Kobayashi Y, Marmur JD. Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER). Am Heart J. 2004 Jan; 147(1):16-22.
      View in: PubMed
    115. Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, Sharma SK. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol. 2004 Jan 1; 93(1):18-23.
      View in: PubMed
    116. Kini AS, Lee PC, Mitre CA, Kim MC, Kamran M, Duffy ME, Marmur JD, Sharma SK. Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome. Am J Med. 2003 Dec 15; 115(9):708-14.
      View in: PubMed
    117. Doshi SN, Kini A, Kim MC, Payne N, Kamran M, Sherman W, Marmur JD, Sharma SK. A comparative study of rotational atherectomy in acute and stable coronary syndromes in the modern era. Am J Cardiol. 2003 Dec 15; 92(12):1404-8.
      View in: PubMed
    118. Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, Sharma S, Hochman JS. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003 Oct 15; 42(8):1373-9.
      View in: PubMed
    119. Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May; 145(5):847-54.
      View in: PubMed
    120. Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration. J Am Coll Cardiol. 2003 Feb 5; 41(3):394-402.
      View in: PubMed
    121. Kini AS, Lee P, Mitre CA, Duffy ME, Sharma SK. Postprocedure chest pain after coronary stenting: implications on clinical restenosis. J Am Coll Cardiol. 2003 Jan 1; 41(1):33-8.
      View in: PubMed
    122. Soma VR, Cavusoglu E, Vidhun R, Frishman WH, Sharma SK. Contrast-associated nephropathy. Heart Dis. 2002 Nov-Dec; 4(6):372-9.
      View in: PubMed
    123. Kini AS, Richard M, Suleman J, Perez N, Lee P, Fisher EA, Kamran M, Marmur JD, Sharma SK. Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). Am J Cardiol. 2002 Sep 1; 90(5):526-9.
      View in: PubMed
    124. Doshi SN, Kim MC, Sharma SK, Fuster V. Images in cardiovascular medicine. Right and left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Circulation. 2002 Jul 9; 106(2):e3-4.
      View in: PubMed
    125. Doshi SN, Sharma SK, Kim MC. Normal coronary arteries and isolated, regional, left ventricular dysfunction in myotonic dystrophy: a case report. Int J Cardiol. 2002 May; 83(2):191-3.
      View in: PubMed
    126. Kini AS, Mitre CA, Kamran M, Suleman J, Kim M, Duffy ME, Marmur JD, Sharma SK. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol. 2002 Apr 15; 89(8):999-1002.
      View in: PubMed
    127. Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol. 2002 Mar 20; 39(6):923-34.
      View in: PubMed
    128. Kini AS, Mitre CA, Kim M, Kamran M, Reich D, Sharma SK. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv. 2002 Feb; 55(2):169-73.
      View in: PubMed
    129. Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carrozza JP, Sharma S, McCormick DJ, Schmidt DA, Lansky AJ, Ho KK, Dandreo KJ, Setum CM, Ramee SR. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol. 2002 Feb 1; 89(3):326-30.
      View in: PubMed
    130. Lev EI, Osende JI, Richard MF, Robbins JA, Delfin JA, Rodriguez O, Sharma SK, Jayasundera T, Badimon JJ, Marmur JD. Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function. J Am Coll Cardiol. 2001 Mar 1; 37(3):847-55.
      View in: PubMed
    131. Kini AA, Sharma SK. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention. Rev Cardiovasc Med. 2001; 2 Suppl 1:S19-25.
      View in: PubMed
    132. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000 Aug 1; 102(5):506-10.
      View in: PubMed
    133. Sharma SK, Kini A, Marmur JD, Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation. 2000 Jul 11; 102(2):166-72.
      View in: PubMed
    134. Dangas G, Machac J, Goldman ME, Sharma SK, Shao JH, Cohen AM, Meraj P, Feldman D, Ambrose JA. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography. Coron Artery Dis. 2000 Jul; 11(5):409-14.
      View in: PubMed
    135. Dangas G, Ambrose JA, Rehmann D, Marmur JD, Sharma SK, Hemdal-Monsen C, Sanborn TA, Fischman DL. Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty. Am J Cardiol. 2000 Apr 15; 85(8):957-61.
      View in: PubMed
    136. Dangas G, Marmur JD, King TE, De Leon J, Sharma SK, Vidhun R, Feldman D, Stoynov MY, Badimon JJ, Ambrose JA. Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention. Am Heart J. 1999 Jul; 138(1 Pt 1):49-54.
      View in: PubMed
    137. Dangas G, Ambrose JA, Sharma SK, Shao JH, Feldman D, Cohen AM, Marmur JD, Cocke TP, Duvvuri S, Goldman ME. The effect of early postinfarction revascularization of asymptomatic patients on left ventricular remodeling. Coron Artery Dis. 1999 Jun; 10(4):203-10.
      View in: PubMed
    138. Dangas G, Dailey-Sterling FG, Sharma SK, Chockalingham S, Albanese JR, Reich DL, Meller J, Fallon JT. Non-Q-wave infarction and ostial left coronary obstruction due to giant Lambl's excrescences of the aortic valve. Circulation. 1999 Apr 13; 99(14):1919-21.
      View in: PubMed
    139. Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G, Ambrose JA, Fallon JT. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol. 1998 Dec; 32(7):2035-42.
      View in: PubMed
    140. Sharma SK, Duvvuri S, Dangas G, Kini A, Vidhun R, Venu K, Ambrose JA, Marmur JD. Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases. J Am Coll Cardiol. 1998 Nov; 32(5):1358-65.
      View in: PubMed
    141. Williams MS, Coller BS, Väänänen HJ, Scudder LE, Sharma SK, Marmur JD. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro). Circulation. 1998 Aug 25; 98(8):742-8.
      View in: PubMed
    142. Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. Arterioscler Thromb Vasc Biol. 1998 Aug; 18(8):1342-9.
      View in: PubMed
    143. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation. 1996 Sep 15; 94(6):1226-32.
      View in: PubMed
    144. Fyfe BS, Israel DH, Quish A, Squire A, Burrows L, Miller C, Sharma SK, Murthy S, Machac J. Reversal of primary hyperoxaluria cardiomyopathy after combined liver and renal transplantation. Am J Cardiol. 1995 Jan 15; 75(2):210-2.
      View in: PubMed
    145. Marmur JD, Merlini PA, Sharma SK, Khaghan N, Torre SR, Israel DH, Ardissino D, Ambrose JA. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol. 1994 Nov 15; 24(6):1484-91.
      View in: PubMed
    Sharma's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067